Bottom Line:
The sample sizes and number of biomarkers identified from these studies do not exclude the risk of false positives, a limitation of all biomarker studies.No financial support was obtained for this project.There are no conflicts of interest.

Bottom Line:
The sample sizes and number of biomarkers identified from these studies do not exclude the risk of false positives, a limitation of all biomarker studies.No financial support was obtained for this project.There are no conflicts of interest.